Amber
4 known investors
Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
JB
Jacob Borrajo, PhDFounder and CEO
Investors · 4
In the news
- Amber Bio - BIO International Convention 2026convention.bio.org · 2026
- The Retinal Degeneration Fund announces investment in Amber Bio | Ophthalmology Times - Clinical Insights for Eye Specialistsophthalmologytimes.com · 2026
- Wilson Sonsini Advises Amber Bio on $26 Million Seed Financing | Wilson Sonsiniwsgr.com · 2023
- Amber Bio Raises $26M in Seed Financingfinsmes.com · 2023
- Amber Bio Launches with $26 Million in Seed Capital for RNA Editing - Global Genesglobalgenes.org · 2023
- Amber Bio Raises $26 Million Seed Financing Co-Led by Playground Global and Andreessen Horowitz to Advance New RNA-Based Gene Editing Platformbusinesswire.com · 2023